Drugwatch Podcast

Listen to health care professionals share their expertise and tips to help you live a better life. Formerly known as Drugwatch Radio, the podcast also features the personal stories of everyday men and women who suffered life-changing side effects from drugs and devices.

Subscribe for Notifications

Meet your Host

Michelle Llamas
Michelle Llamas

Michelle is a writer and researcher for Drugwatch.com. She interviews medical experts, patient advocates and consumers affected by dangerous drugs and devices.

Latest Episodes

Part II: Transvaginal Mesh Survivor Tells Other Women: ‘Do Not Give Up’

Welcome to Part Two of our interview with mesh survivor Christy Hammond, founder of SurvivingMESH.org, and her attorney, Karen Beyea-Schroeder. In this podcast episode, Christy [...]

Go To Episode

Part I: Transvaginal Mesh Survivor Offers Hope to Other Women

During Part One of a special two-part episode of Drugwatch Podcast, Christy Hammond shares her harrowing experience with transvaginal mesh, her opinions on lawsuits and [...]

Go To Episode

Part II: Consumer Reports Official Advocates for Warranties on Medical Devices

Welcome to the second half of our two-part podcast featuring Lisa McGiffert, director of Consumers Union’s Safe Patient Project, the policy arm of Consumer Reports. [...]

Go To Episode

Part I: Consumer Reports Official Advocates for Warranties on Medical Devices

Welcome to a special two-part podcast featuring Lisa McGiffert, director of Consumers Union’s Safe Patient Project, the policy arm of Consumer Reports, a publication trusted [...]

Go To Episode

UCLA Orthopaedic Surgeon Discusses Hip Replacement Surgery and Implant Complications

Dr. Bert J. Thomas, orthopaedic surgeon and chief of Joint Replacement Service at UCLA Medical Center, recently phoned in from California to discuss hip replacement [...]

Go To Episode
1 3 4 5

Sign Up for Drugwatch Podcast & Newsletter Alerts

Stay up to date on the latest podcast and drug and device news from Drugwatch.

    Thank You!

    You will now receive updates from Drugwatch.